Resources
Filter by Topic
- Booklets
8 FDA-Recognized Success Stories of Real-World Evidence (RWE) in Regulatory Approvals
- Articles
Panalgo’s Andrew Goldstein (VP, Client Partnerships) and Niyati Parikh, (VP, Product Readiness) discuss how to use real-world data and AI ethically and transparently to illuminate...
- Articles
Michael Munsell, PhD (Norstella), discusses why using real-world data (RWD) is key to evaluating how the Inflation Reduction Act (IRA) affects patient outcomes and health...
- Articles
Panalgo’s Niyati Parikh (VP, Product Readiness) discusses how GenAI can make insights more transparent, accessible and actionable across teams.
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 2)
In our previous blog post, we sat down with Dr. Samy Suissa, the co-founder and principal investigator of the Canadian Network for Observational Drug Effect Studies,
The Importance of Accounting for Time-Related Bias in Single-Arm Trials with Historical Controls (Part 1)
Randomized control trials (RCTs) are typically heralded as the gold standard in clinical trial design. However, regulatory agencies are increasingly recognizing the role of single-arm
Using Machine Learning in the Evolving Landscape of Real-World Data
In this article with HIT Consultant, Zeynep Icten, PhD, (Director of Data Science Solutions at Panalgo) discusses the predictive power of machine learning for healthcare
Webinar – Preparing a Successful ICER Strategy: Lessons from the Frontlines
How do you prepare for a successful ICER strategy? We asked three industry experts what the key components of a successful ICER evaluation strategy are
Panalgo to Present at ISPOR Europe 2021
Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database. Zeynep Icten, MS,
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization